FDA Inspection 674356 — Prostrakan Inc.

Prostrakan Inc. — FEI 3006973519

The FDA completed an inspection of Prostrakan Inc. on Aug 3, 2010 in Bedminster, NJ. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 2 citations were issued during this inspection. Product area: Drugs.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Aug 3, 2010
Fiscal Year
2010
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Bedminster, NJ (United States)

Additional details

Postmarket Adverse Drug Experience (PADE)

Citations

IDCFRDescription
670421 CFR 310.305(c)Submission of report to incorrect office
683321 CFR 314.80(c)(2)(ii)(A)Incomplete periodic safety report

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.